Risk Factors for Lower Extremity Overuse Injuries in Jump-landing Athletes

August 23, 2024 updated by: University Ghent

Biomechanical (Fatigue-related) Risk Factors for the Development of Lower Extremity Overuse Injuries in Jump-landing Athletes

In this prospective study, male jump-landing athletes (volleyball and basketball) will be screened pre-season and followed for one consecutive season. Pre-season screening consists of 3D biomechanical analysis of standardized (such as drop vertical jump) and sports-specific jumps (such as stop-jump) before and after a high-intensity, intermittent exercise protocol and clinical field tests (such as force measurements).

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

150

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Oost-Vlaanderen
      • Gent, Oost-Vlaanderen, Belgium, 9000
        • Vakgroep Revalidatiewetenschappen

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Healthy jump-landing athletes

Description

Inclusion Criteria:

  • volleyball and basketball players
  • elite and non-elite
  • male
  • healthy

Exclusion Criteria:

  • symptoms or complaints of lower extremity acute of overuse injuries in the past 3 months
  • history or surgery of the lower extremities
  • history of fractures of the lower extremities

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Jump-landing biomechanics
Time Frame: 1 year
Full-body (trunk, pelvis, hip, knee, ankle) jump-landing biomechanics (3D joint angles and moments) during drop vertical jumps, block jumps and spike jumps
1 year
Jump-landing biomechanics after fatigue
Time Frame: 1 year
Full-body (trunk, pelvis, hip, knee, ankle) jump-landing biomechanics (3D joint angles and moments) during spike jumps during and after a fatigue protocol
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical tests - force
Time Frame: 1 year
Force measurements of the quadriceps, hamstrings and gluteal muscles by means of hand-held dynamometry
1 year
Clinical tests - mobility
Time Frame: 1 year
Flexibility of the quadriceps and hamstrings muscles, and ankle dorsiflexion angle during dynamic weight-bearing lunge
1 year
Clinical tests - foot posture
Time Frame: 1 year
Navicular height and position of the calcaneal bone
1 year
Clinical tests - force endurance
Time Frame: 1 year
Prone bridge until fatigue
1 year
Clinical tests - endurance
Time Frame: 1 year
Intermittent yo-yo test (level 1)
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Roosen, University of Ghent

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2021

Primary Completion (Actual)

August 1, 2022

Study Completion (Actual)

August 20, 2024

Study Registration Dates

First Submitted

November 24, 2021

First Submitted That Met QC Criteria

December 3, 2021

First Posted (Actual)

December 17, 2021

Study Record Updates

Last Update Posted (Actual)

August 26, 2024

Last Update Submitted That Met QC Criteria

August 23, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • B6702020000525-3

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fatigue

Subscribe